The Drug Eluting Stents Center

Filter Your Results




Safety and Efficacy Data Presented for BD's Lutonix DCB in Below-the-Knee Arteries

May 1, 2019 -- Patrick Geraghty, MD, presented 6-month results from the Lutonix BTK trial at the 2019 Charing Cross Symposium, held April 15 -- 18 in London, United Kingdom. T…

FDA Schedules Public Meeting on Paclitaxel Use in PAD

April 22, 2019 -- The FDA announced that the Circulatory System Devices Panel of the Medical Devices Advisory Committee will convene a public meeting to discuss and make recom…

Cook Medical Provides Patient-Level Paclitaxel Data From Zilver PTX Randomized Controlled Trial

April 18, 2019 -- Cook Medical announced that patient-level data from the Zilver PTX randomized controlled trial (RCT) of the company's paclitaxel-eluting peripheral stent…

Two-Year Data Presented From BIOLUX P-III Registry of Biotronik's Passeo-18 Lux DCB

April 18, 2019 -- Biotronik announced that 2-year data from the BIOLUX P-III all-comers registry of the company's Passeo-18 Lux drug-coated balloon (DCB) were presented at…

Enrollment Resumes in the TRANSCEND Trial of Surmodics' SurVeil Paclitaxel-Coated Balloon

April 17, 2019 -- Surmodics, Inc. announced that it has resumed patient enrollment for the TRANSCEND clinical trial and has completed approximately 75% of its goal of enrollin…

IMPERIAL Subanalyses Support Boston Scientific's Eluvia Stent in Calcified Lesions and CTOs

April 16, 2019 -- Boston Scientific Corporation announced that results from subanalyses of the IMPERIAL clinical trial for the company's Eluvia drug-eluting vascular stent…

CIRSE Position Statement Addresses the Use of Paclitaxel-Coated Devices in PAD

April 12, 2019 -- The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) announced an updated CIRSE Position Statement on the use of paclitaxel-coated ba…

Cook Medical Letter to Physicians Addresses Paclitaxel Data

March 26, 2019 -- In a letter to physicians, Cook Medical communicated the company's latest information and insights regarding concerns about long-term safety of paclitaxe…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.